Skip to main content
S 4152 117th Congress Senate Health

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Introduced: May 5, 2022 Introduced by: Kelly, Mark Democratic · Arizona See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 5, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 5, 2022
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.

What's happening now May 5, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 3
  • HR 7667 Related bill Food and Drug Amendments of 2022
  • S 4348 Related bill FDASLA Act of 2022
  • HR 7658 Identical bill To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Collins, Susan M.
Maine · May 5, 2022
Cite this page click to expand
APA
U.S. Congress. (2026). S. 4152: A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.. 117th Congress. Open America. https://openamerica.io/bill/117-S-4152/
MLA
"S. 4152: A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4152/.
Bluebook (legal)
S. 4152, 117th Cong. (2026), https://openamerica.io/bill/117-S-4152/.
Markdown link
[S. 4152: A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.](https://openamerica.io/bill/117-S-4152/)
Report a problem